Teleflex Receives Reimbursement Approval for the UroLift® System in Japan

NEXT STORY
Autolus Therapeutics presents positive obe-cel data at the 63rd ASH Annual Meeting & Exposition
PREV STORY
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Expanded three-month Phase 2 data presented at EULAR 2018 continue to indicate that SEL-212 ...

author_avatar
NASDAQ Market News

Pluristem Concludes Positive Meeting with FDA on Development Plan for Acute Radiation Syndrome

Meeting included representatives from NIH and BARDAHAIFA, Israel, Jan. 03, 2019 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News

Dynavax Reports Fourth Quarter and Year End 2017 Financial Results

HEPLISAV-B Launched in the United States Phase 2 Data in Two Immuno-oncology Programs Planned ...

author_avatar
NASDAQ Market News